Literature DB >> 11809775

Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on.

Martin Bergö1, Gengshu Wu, Toralph Ruge, Thomas Olivecrona.   

Abstract

During short term fasting, lipoprotein lipase (LPL) activity in rat adipose tissue is rapidly down-regulated. This down-regulation occurs on a posttranslational level; it is not accompanied by changes in LPL mRNA or protein levels. The LPL activity can be restored within 4 h by refeeding. Previously, we showed that during fasting there is a shift in the distribution of lipase protein toward an inactive form with low heparin affinity. To study the nature of the regulatory mechanism, we determined the in vivo turnover of LPL activity, protein mass, and mRNA in rat adipose tissue. When protein synthesis was inhibited with cycloheximide, LPL activity and protein mass decreased rapidly and in parallel with half-lives of around 2 h, and the effect of refeeding was blocked. This indicates that maintaining high levels of LPL activity requires continuous synthesis of new enzyme protein. When transcription was inhibited by actinomycin, LPL mRNA decreased with half-lives of 13.3 and 16.8 h in the fed and fasted states, respectively, demonstrating slow turnover of the LPL transcript. Surprisingly, when actinomycin was given to fed rats, LPL activity was not down-regulated during fasting, indicating that actinomycin interferes with the transcription of a gene that blocks the activation of newly synthesized LPL protein. When actinomycin was given to fasted rats, LPL activity increased 4-fold within 6 h, even in the absence of refeeding. The same effect was seen with alpha-amanitin, another inhibitor of transcription. The response to actinomycin was much less pronounced in aging rats, which are obese and insulin-resistant. These data suggest a default state where LPL protein is synthesized on a relatively stable mRNA and is processed into its active form. During fasting, a gene is switched on whose product prevents the enzyme from becoming active even though synthesis of LPL protein continues unabated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809775     DOI: 10.1074/jbc.M200325200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.

Authors:  Terje Robal; Mikael Larsson; Miina Martin; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone.

Authors:  G D Tan; G Olivecrona; H Vidal; K N Frayn; F Karpe
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

Review 3.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Authors:  O Adeyo; C N Goulbourne; A Bensadoun; A P Beigneux; L G Fong; S G Young
Journal:  J Intern Med       Date:  2012-11-01       Impact factor: 8.989

4.  Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.

Authors:  Xinxin Yu; Shawn C Burgess; Hongfei Ge; Kenny K Wong; R Haris Nassem; Daniel J Garry; A Dean Sherry; Craig R Malloy; Joel P Berger; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

5.  Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.

Authors:  Valentina Sukonina; Aivar Lookene; Thomas Olivecrona; Gunilla Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

6.  Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.

Authors:  Yan Wang; Markey C McNutt; Serena Banfi; Michael G Levin; William L Holland; Viktoria Gusarova; Jesper Gromada; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

7.  Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low-intensity activity.

Authors:  Lionel Bey; Marc T Hamilton
Journal:  J Physiol       Date:  2003-06-18       Impact factor: 5.182

8.  Programmed upregulation of adipogenic transcription factors in intrauterine growth-restricted offspring.

Authors:  Mina Desai; Monica Ferelli; Natash Kallichanda; Robert H Lane
Journal:  Reprod Sci       Date:  2008-10       Impact factor: 3.060

Review 9.  GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.

Authors:  Stephen G Young; Brandon S J Davies; Loren G Fong; Peter Gin; Michael M Weinstein; André Bensadoun; Anne P Beigneux
Journal:  Curr Opin Lipidol       Date:  2007-08       Impact factor: 4.776

10.  The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.

Authors:  Lu Shan; Xuan-Chuan Yu; Ziye Liu; Yi Hu; Lydia T Sturgis; Maricar L Miranda; Qingyun Liu
Journal:  J Biol Chem       Date:  2008-11-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.